Oxford Events, the new replacement for OxTalks, will launch on 16th March. From now until the launch of Oxford Events, new events cannot be published or edited on OxTalks while all existing records are migrated to the new platform. The existing OxTalks site will remain available to view during this period.
From 16th, Oxford Events will launch on a new website: events.ox.ac.uk, and event submissions will resume. You will need a Halo login to submit events. Full details are available on the Staff Gateway.
Alzheimer’s disease (AD) is the leading cause of dementia worldwide, with no cure currently available. AD pathogenesis is primarily driven by cerebral accumulation of β-amyloid (Aβ), a small peptide and proteolytic cleavage product of amyloid-β precursor protein (APP). Elucidating molecular mechanisms that change Aβ levels and APP processing could provide new insights for understanding disease etiology; and development of interventions that attenuate amyloid pathology may provide useful therapeutics for AD.
